Law ❯ Corporate Law ❯ Securities Regulation

Litigation

Investor Protection Class Action Class Action Lawsuits Investor Rights Fiduciary Duties Mergers and Acquisitions Misrepresentation Whistleblower Protections Class Action Procedures Shareholder Lawsuits Proxy Battles Antitrust Issues Misreporting

Soleno Therapeutics Sued in Federal Securities Class Action Over DCCR Safety Disclosures

Investors have until May 5, 2026 to seek lead-plaintiff status in a case alleging misstatements about the Prader–Willi syndrome drug’s risks.

SLM Investors Face Feb. 17 Deadline to Seek Lead Role in Securities Fraud Suit

Fluor Hit With Securities Class Action Over Cost Overruns and 2025 Guidance